A
$ Value
$0
Shares
30,000
Price
$0
Filed
Feb 13
Insider
Name
Blackburn Kelly
Title
EVP, Clinical Development
CIK
0001640575
Roles
Officer
Transaction Details
Transaction Date
2026-02-11
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
30,000
Footnotes
The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2026.
Filing Info
Blackburn Kelly's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-11 | CRVO | A | $0 |
Other Insiders at CRVO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALAM JOHN J
CEO & President
|
— | — | 2026-02-11 |
| Gregoire Sylvie | — | — | 2026-02-11 |
|
ELDER WILLIAM ROBERT
CFO, GC & Secretary
|
— | — | 2026-02-11 |
|
De Rosch Mark
EVP, RA and GA and PgM
|
— | — | 2026-02-11 |
|
Winton Matthew
Chief Commercial and Business
|
— | — | 2026-02-11 |